Business Insights, March 2008, Pages: 280
pharma companies becoming increasingly dependant upon the technology platforms and approaches adopted by biotech companies.
The Fastest Growing BiotechnologyCompanies: Growthstrategies, comparative
Jain PharmaBiotech, Feb 2012, Pages: 348
companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnologycompanies. Top companies in this area
RNCOS E-Services Private Limited, Feb 2011, Pages: 90
are the focus areas of both the government and private market players. Under National Biotechnology Program, the authorities have extensively planned out various strategies and goals regarding each
GBI Research, Dec 2010, Pages: 198
landscape in the US, Europe and Japan.
In 2009 the Biotechnology Industry was Dominated by the Top 10 Companies
The biotechnology industry has emerged as a major growth area in the global healthcare
Taiyou Research, June 2011, Pages: 430
Research presents an analysis of the Global Biotechnology Market in its cutting-edge report which covers 24 countries and 62 companies in an in-depth analysis.
The report covers the following:
- A complete coverage
RNCOS E-Services Private Limited, Nov 2010, Pages: 165
of biotechnology.
The report further presents valuable information to the pharmaceutical & biotechnologycompanies and investors, planning to enter these markets and will help them to devise strategies
GlobalData, Sep 2011, Pages: 35
of Health for development of its anti-cancer treatments. The company is headquartered in East Seta, New York, the US.
Lixte Biotechnology Holdings, Inc. Key Recent Developments
Aug 11, 2011: Lixte
GlobalData, Feb 2012, Pages: 28
with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed
Business Insights, Dec 2006, Pages: 103
of their technologies, changing the approach of out-licensing at various stages of the lifecycle and highlighting the need for biotechnologycompanies to adapt existing strategies to optimize this process. ‘Biopartnering
GlobalData, Sep 2011, Pages: 39
with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed
Global Industry Analysts, Inc., Oct 2010, Pages: 446
5
Agricultural Biotechnology Surges Ahead 5
Growth Spreads to All Corners of the Globe 6
Agricultural Biotechnology
GBI Research, Feb 2010, Pages: 181
of individual companies and the opportunities and threats facing them.
The Average Growth in the Biotechnology Industry Has Been More than That of the Global Pharmaceutical Industry
The biotechnology industry
Global Markets Direct, March 2011, Pages: 42
from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Prana Biotechnology Limited - Brief company overview including business description, key
Taiyou Research, June 2011, Pages: 130
The Indian biotechnology industry has been growing substantially in the last couple of years. Biotech companies have grown in the country exponentially as a liberalized intellectual property regime
Business Insights, Feb 2010, Pages: 146
for manufacturing marketed drugs.
Sourcing APIs from low-cost suppliers is a key strategy for pharmaceutical companies pressured by the emerging ‘patent cliff’. The model of vertical integration that dominated
Global Industry Analysts, Inc., April 2011, Pages: 402
period of high growth, as drug developers worldwide are looking to India as a low-cost destination for outsourcing their discovery and production work.
Biotechnology is touted as the next big thing
MarketLine, Sep 2011, Pages: 32
&A, private equity, and partnerships and alliances.
– Form an independent opinion about Stellar Biotechnologies, Inc. (formerly CAG Capital, Inc.)’s growthstrategies through the organic and inorganic
Axis Research Mind, Feb 2011, Pages: 412
strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnologycompanies, laboratories, Contract
